Shareholder litigation

搜索文档
INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Paramount Group, Inc. to Contact Law Firm
Prnewswire· 2025-05-21 22:14
NEW YORK, May 21, 2025 /PRNewswire/ -- Moore Law, PLLC, a shareholder litigation law firm located on Wall Street, is investigating potential claims against: Paramount Group Inc. (NYSE: PGRE) Shareholders should email [email protected]; please contact only if shares acquired before 2022 The investigation concerns a Wall Street Journal article outing Chief Executive Albert Behler for tapping company coffers to the tune of $4,000,000.00 to fund his personal expenses and business interests and his wife's busin ...
WST INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
GlobeNewswire News Room· 2025-05-20 13:50
公司诉讼案件 - 西氏医药服务公司因涉嫌违反1934年证券交易法被提起集体诉讼 案件编号为No 25-cv-02285 [1] - 诉讼指控公司在2023年2月16日至2025年2月12日期间做出虚假和/或误导性陈述 [1][3] - 诉讼涉及公司高管及前高管 原告为新英格兰卡车司机养老金基金 [1] 公司业务情况 - 西氏医药主要从事注射药物和医疗产品的密封包装和给药系统设计与制造 [2] - 公司高利润的高价值产品组合持续经历显著去库存 与公司声称的"临时性COVID相关去库存"不符 [3] - SmartDose设备因运营效率低下严重稀释公司利润率 该产品本被定位为高利润增长产品 [3] 财务与运营问题 - 公司2025年收入指引为28 8-29 1亿美元 大幅低于预期 [4] - 利润率压力导致公司退出长期客户的连续血糖监测(CGM)合同 [3] - SmartDose可穿戴注射器因降价将在2025年继续稀释利润率 [4] 市场反应 - 2025年2月13日公司发布上述消息后 股价暴跌超过38% [4] - 公司解释业绩不佳部分原因是合同制造业务面临挑战 包括失去两个主要CGM客户 [4]
CIVI INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Civitas Resources, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
GlobeNewswire News Room· 2025-05-18 15:30
SAN DIEGO, May 18, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Civitas Resources, Inc. (NYSE: CIVI) securities between February 27, 2024 and February 24, 2025, all dates inclusive (the “Class Period”), have until July 1, 2025 to seek appointment as lead plaintiff of the Civitas Resources class action lawsuit. Captioned Lin v. Civitas Resources, Inc., No. 25-cv-03791 (D.N.J.), the Civitas Resources class action lawsuit charges Civitas Resources as well ...
Ibotta Shareholders Should Contact Shareholder Rights Firm Regarding Potential Legal Claims
Prnewswire· 2025-05-17 12:00
公司调查 - 顶级股东权利律师事务所Julie & Holleman LLP正在调查Ibotta Inc及其高管可能存在的索赔案件 因公司股东近期遭受损失 [1] - 调查涉及Ibotta及其高管可能误导投资者关于其大客户The Kroger Co相关风险的信息 且公司IPO价格为每股88美元后股价大幅下跌 [2] - 律师事务所正在调查针对Ibotta高管及董事会的法律索赔 该律所此前在类似案件中已帮助客户获得数亿美元赔偿 [3] 律所背景 - Julie & Holleman为专注于股东诉讼的精品律所 业务范围包括衍生诉讼 并购案件 证券欺诈集体诉讼及公司调查 [4] - 律所律师在全美各州及联邦法院参与诉讼 累计为公司及股东挽回数亿美元损失 [4]
Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm
GlobeNewswire News Room· 2025-05-15 14:14
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Doximity, Inc. (NYSE: DOCS) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Doximity caused the company to misrepresent or fail to disclose material information concerning the Company’s business and operations. Specifically, the Complaint alleges Defendants repeatedly touted the Company’s business pro ...
Kuehn Law Encourages Investors of SoundHound AI, Inc. to Contact Law Firm
Prnewswire· 2025-05-15 00:48
NEW YORK, May 14, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of SoundHound AI, Inc. (NASDAQ: SOUN) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at SoundHound caused the company to misrepresent or fail to disclose that (i) the material weaknesses in SoundHound's internal controls over financial reporting impaired the Company's ability to effectively account for corpora ...
Kuehn Law Encourages Investors of Neumora Therapeutics, Inc. to Contact Law Firm
Prnewswire· 2025-05-14 19:50
公司调查 - Kuehn Law PLLC正在调查Neumora Therapeutics Inc (NASDAQ NMRA)的某些高管和董事是否违反了对股东的受托责任 [1] 诉讼指控 - 联邦证券诉讼指控Neumora Therapeutics内部人士导致公司存在虚假陈述或未披露关键信息 [2] - 公司被迫修改BlackThorn原始二期试验的纳入标准 将患者群体扩大到中度至重度MDD以证明Navacaprant在治疗MDD方面具有统计学显著改善 [2] - 公司还在二期统计分析计划中增加了针对中度至重度MDD患者的预设分析 [2] - 二期试验数据不足 特别是在患者群体规模和男女比例方面 无法准确预测KOASTAL-1研究结果 [2] 股东行动 - 在2023年9月15日前购买NMRA股票的股东可联系Kuehn Law参与调查 [3] - 律所承担所有案件费用 不向投资者客户收费 [3] - 股东需立即联系律所 因行使权利的时间可能有限 [3]
CIVI INVESTOR ALERT: Civitas Resources, Inc. Investors with Substantial Losses Have Opportunity to Lead the Civitas Resources Class Action Lawsuit
Prnewswire· 2025-05-05 20:03
诉讼案件概述 - Civitas Resources面临集体诉讼,指控其在2024年2月27日至2025年2月24日期间违反《1934年证券交易法》[1] - 诉讼指控公司高管在Class Period内作出虚假或误导性陈述,并隐瞒关键运营与财务风险[3] 公司业务与运营情况 - 公司专注于科罗拉多州Denver-Julesburg盆地及得克萨斯州、新墨西哥州Permian盆地的原油与富液天然气勘探开发[2] - 2024年公司维持稳定原油产量并加速新钻井(TILs)投产,横跨DJ与Permian盆地[2] 指控核心内容 - 公司未披露2025年原油产量将因DJ盆地产量峰值后自然衰减及2024年末TIL数量不足而显著下降[3] - 增产需通过收购新地块实现,将导致债务激增并被迫出售资产抵消成本[3] - 财务状况迫使公司实施10%全员裁员并解雇首席运营官与首席转型官[4] 财务数据与市场反应 - 2024年Q4营收12.9亿美元,低于共识预期344万美元,非GAAP每股收益1.78美元,低于预期0.21美元[4] - 2025年产量指引为日均15-15.5万桶,同比下滑4%,主因DJ盆地产量衰减及Q1恶劣天气影响[4] - 宣布3亿美元Permian盆地收购计划及3亿美元资产剥离目标以平衡交易成本[4] - 财报发布后股价单日跌幅超18%[4] 法律程序信息 - 投资者可在2025年7月1日前申请成为首席原告,主导集体诉讼进程[1][5] - 首席原告需为遭受重大损失且符合典型性要求的投资者,有权选择代理律所[5]
Kuehn Law Encourages Investors of WEBTOON Entertainment Inc. to Contact Law Firm
Prnewswire· 2025-04-01 18:35
公司调查 - Kuehn Law PLLC正在调查WEBTOON Entertainment Inc (NASDAQ: WBTN)的某些高管和董事是否违反了对股东的受托责任 [1] 诉讼指控 - 联邦证券诉讼指控WEBTOON内部人士导致公司存在以下问题:广告收入增长放缓 [2] - IP改编收入增长放缓 [2] - 公司面临外汇走弱的影响,抵消了收入增长 [2] - 由于上述原因,公司关于业务、运营和前景的正面陈述存在重大误导或缺乏合理依据 [2] 股东参与 - 股东参与有助于维护金融市场的完整性和公平性 [4] - 股东可通过联系Kuehn Law PLLC来维护自身权益 [3]